This suggests that PSMB6 may alter the release of cytokines within the immune microenvironment by influencing leukocyte proliferation and cellular activation involved in immune responses, ultimately impacting the activity of lung adenocarcinoma cells. This evidence concerns the gene PSMB6 and lung adenocarcinoma.